Rahaman Sk Hammadur, Jyotsna Viveka P, Kandasamy Devasenathipathy, Shreenivas V, Gupta Nandita, Tandon Nikhil
Department of Endocrinology, AIIMS, New Delhi, India.
Department of Radiology, AIIMS, New Delhi, India.
Indian J Endocrinol Metab. 2018 Nov-Dec;22(6):766-769. doi: 10.4103/ijem.IJEM_160_18.
Osteoporosis is a well-recognized complication of Cushing's syndrome (CS). Data on bone health in patients with CS from south Asian countries, which are vitamin D deficient, are scarce.
We assessed bone mineral density (BMD) in patients with CS in comparison to controls. We also looked into how BMD differs in different types of endogenous CS.
Thirty-seven cases of CS and 48 matched controls were studied for clinical, biochemical, hormonal, and bone densitometry parameters.
BMD (both total lumbar spine (LS) and hip) as well as scores were significantly lower in CS patients as compared to controls. Neither LS nor hip BMD was significantly different among different etiological groups of CS. The difference in BMD was also not significant between eumenorrhoeic and oligo-/amenorrhoeic patients with CS.
Patients with CS are at increased risk of having fracture secondary to osteopenia and osteoporosis. There is no significant association of vitamin D and intact parathormone with low BMD in patients with CS.
骨质疏松症是库欣综合征(CS)一种公认的并发症。来自维生素D缺乏的南亚国家的CS患者的骨骼健康数据很少。
我们评估了CS患者与对照组相比的骨密度(BMD)。我们还研究了不同类型的内源性CS中BMD的差异。
对37例CS患者和48例匹配的对照者进行了临床、生化、激素和骨密度测量参数的研究。
与对照组相比,CS患者的BMD(全腰椎(LS)和髋部)以及评分显著降低。CS不同病因组之间的LS和髋部BMD均无显著差异。CS患者中,月经正常与月经稀少/闭经患者之间的BMD差异也不显著。
CS患者因骨质减少和骨质疏松而发生骨折的风险增加。CS患者中维生素D和完整甲状旁腺激素与低BMD无显著关联。